Looking to publish in Transplantation and Cellular Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginTransplantation and Cellular Therapy is the official publication of the American Society for Transplantation and Cellular Therapy and focuses on the interdisciplinary field of hematopoietic cell transplantation and cellular therapies. The journal emphasizes clinical care, treatment outcomes, standards, best practices, evidence-based approaches, current technology, groundbreaking research, and clinical applications. It publishes original research reports, practice guidelines, reviews, editorials, commentaries, and letters to the editor.
Looking to publish in Transplantation and Cellular Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Transplantation and Cellular Therapy accepts the following article types. Click on an article type to view submission instructions.
Regular Manuscripts
Review Articles
Clinical Reviews
Research Communications
Letters
Recent Publications
Barriers to Patient Referral and Completion of CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma
Mazyar Shadman, Jenny Ahlstrom, Meghan Gutierrez, Loretta Nastoupil, David Porter, Ashley Schmitt, Laura Zitella, Tara Graff
ASTCT Consensus Grading for Toxicities after Immune Effector Cell Therapy
Miguel-Angel Perales, Jorg Dietrich, Juliane Gust, Bianca Santomasso, Kai Rejeski, Doris Hansen, Nirali N. Shah, Jesus Berdeja, Michael Bishop, Eric Bleickardt, Jennifer Brudno, Saurabh Dahiya, Noelle Frey, Matthew J. Frigault, Rebecca Gardner, Armin Ghobadi, Stephan Grupp, Mehdi Hamadani, Caron Jacobson, Michael D. Jain, Tania Jain, Krishna V. Komanduri, Anupama Kumar, Stephen Lim, Yi Lin, Harry Miao, Sattva Neelapu, Folashade Otegbeye, Jae H. Park, Marcelo Pasquini, Nitin Patel, Gregory Plautz, Nicole Verdun, Daniel W. Lee, Marcela V. Maus, Frederick L. Locke
Fludarabine and Total Body Irradiation 800 cGy or 1125 cGy For Allogeneic Stem Cell Transplant Using Graft Versus Host Disease Prophylaxis With Post-Transplant Cyclophosphamide and Tacrolimus, Without Mycophenolate Mofetil (OmitMMF trial)
Ronald Paquette, Haein Kim, Vinicius F. Calsavara, Noah Merin, John Chute, Justin Darrah, Hannah Lee, David Oveisi, Josh Sasine, Robert Vescio, Vanshika Chauhan, Joseph Lownik, Akil Merchant
Delayed Neurologic and Enterocolitis Reporting Patterns for Ciltacabtagene Autoleucel Versus Idecabtagene Vicleucel in EudraVigilance
Tomasz Buczek, Patrycjusz Barnaś, Kuba Ptaszkowski, Aleksandra Butrym
Effect of Stem Cell Cryopreservation on Day 60 Donor Chimerism in Unrelated Donor Allogeneic Stem Cell Transplantation using Reduced Intensity Conditioning and ATG-based GVHD Prophylaxis.
Yaqeen Abduallah, David Allan, Harold Atkins, Christopher Bredeson, Natasha Kekre, Michael Kennah, Ashish Masurekar, Santhosh Thyagu, Ram Vasudevan Nampoothiri
Frequently asked questions
How long does it take to publish?
3 days from submission to first decision; 29 days from submission to decision after review; 74 days from submission to acceptance; 5 days from acceptance to online publication.
Reformat to Transplantation and Cellular Therapy using Livewrite PremiumIs a cover letter required?
A cover letter is required. It should identify the corresponding author’s name, address, phone number, fax number, and e-mail address, specify the manuscript category and word count, include prior peer review information for Fast Track submissions, and indicate willingness to pay extra costs for color photographs when applicable.
Reformat to Transplantation and Cellular Therapy using Livewrite PremiumWhat are the publication costs?
Open access APC is USD 4000 excluding taxes for all articles. Subscription publication has no open access publication fee.
Reformat to Transplantation and Cellular Therapy using Livewrite Premium